Breaking News Instant updates and real-time market news.

AMGN

Amgen

$170.26

0.55 (0.32%)

13:48
11/29/17
11/29
13:48
11/29/17
13:48

Piper still bullish on Amgen after management meeting

Piper Jaffray analyst Christopher Raymond says he remains bullish on Amgen shares after hosting the company's management at his firm's healthcare conference. The analyst sees near-term pipeline catalysts from Amgen's immuno-oncology approach, which he sees coming more into focus, Repatha label expansion, Parsabiv launch and Aimovig approval/launch next year. Raymond maintains an Overweight rating on the shares with a $190 price target.

  • 29

    Nov

  • 29

    Nov

  • 02

    Dec

  • 18

    Jan

  • 03

    Feb

  • 30

    Apr

  • 17

    May

  • 28

    May

AMGN Amgen
$170.26

0.55 (0.32%)

10/30/17
PIPR
10/30/17
NO CHANGE
PIPR
Overweight
Piper says Europe may be real battleground for biosimilar Soliris threat
Piper Jaffray analyst Christopher Raymond noted that Amgen (AMGN) recently gained EU authorization to conduct a 40 patient, cross-over design Phase 3 trial comparing their biosimilar eculizumab to Alexion's (ALXN) Soliris. He also found evidence of Amgen's active opposition to Alexion's IP extension efforts in Europe. Raymond said many "breathed a sigh of relief" that Soliris' U.S. position on Soliris appears safe out to 2027, but he said these new signs make it appear the real battleground may be Europe. He keeps an Overweight rating on Alexion, stating that "while noise from this challenge won't go away," he thinks the company is well equipped to run its defense.
10/31/17
PIPR
10/31/17
NO CHANGE
Target $170
PIPR
Overweight
Piper says Amgen more credible biosimilar threat to Alexion in Europe
Piper Jaffray analyst Christopher Raymond believes Amgen's (AMGN) threat of a biosimilar alternative to Alexion Pharmaceuticals' (ALXN) Soliris may be more credible and near-term than he previously thought. The analyst highlights a Phase 3 study recently listed in the European Union's Clinical Trials Registry, which was authorized in August, as well as evidence of Amgen's active opposition to Alexion's intellectual property extension efforts in Europe. He reminds investors that two-thirds of Soliris' revenue is outside the U.S. Given this new evidence, "it would appear the real battleground may be Europe," Raymond tells investors in a research note. He keeps an Overweight rating on Alexion with a $170 price target. He views the company as well positioned to defend itself against Amgen.
11/01/17
ARGS
11/01/17
DOWNGRADE
ARGS
Hold
Amgen downgraded to Hold from Buy at Argus
11/01/17
ARGS
11/01/17
DOWNGRADE
ARGS
Hold
Amgen downgraded to Hold at Argus on secular slowdown in sales of top drugs
As reported earlier, Argus analyst David Toung downgraded Amgen to Hold from Buy, noting a "secular" slowdown in sales of the company's top three products - Enbrel, Neulasta and Aranesp. Toung says the sales of growth prospects Prolia, Kyprolis and Repatha are not yet large enough to offset the declines in the three established drugs which face generic competition after losing patent protection. The analyst notes that Amgen may not generate commercial revenue from biosimilars until 2019 due to regulatory and legal challenges.

TODAY'S FREE FLY STORIES

FOXA

21st Century Fox

$33.66

0.36 (1.08%)

, DIS

Disney

09:12
12/12/17
12/12
09:12
12/12/17
09:12
Periodicals
Fox sees remaining assets worth at least $10 per share, CNBC reports »

21st Century Fox (FOXA)…

FOXA

21st Century Fox

$33.66

0.36 (1.08%)

DIS

Disney

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

bluebird bio

$201.80

30.65 (17.91%)

09:11
12/12/17
12/12
09:11
12/12/17
09:11
Recommendations
bluebird bio analyst commentary  »

bluebird bio price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

PFG

Principal Financial

09:11
12/12/17
12/12
09:11
12/12/17
09:11
Hot Stocks
Principal Financial expects to deploy $900M-$1.3B of capital in 2018 »

Principal Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

CLRO

ClearOne

$9.00

0.1 (1.12%)

09:11
12/12/17
12/12
09:11
12/12/17
09:11
Hot Stocks
ClearOne awarded patent relating to smart audio systems and IoT »

ClearOne announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMNY

Helios and Matheson

$9.13

0.68 (8.05%)

, COST

Costco

$188.86

0.79 (0.42%)

09:11
12/12/17
12/12
09:11
12/12/17
09:11
Hot Stocks
Breaking Hot Stocks news story on Helios and Matheson, Costco »

MoviePass, Fandor partner…

HMNY

Helios and Matheson

$9.13

0.68 (8.05%)

COST

Costco

$188.86

0.79 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

09:10
12/12/17
12/12
09:10
12/12/17
09:10
General news
Analysts saw solid November U.S. PPI gains »

Analysts saw solid…

MA

MasterCard

$150.88

0.99 (0.66%)

09:09
12/12/17
12/12
09:09
12/12/17
09:09
Hot Stocks
MasterCard: New digital platform offers holistic management for prepaid accounts »

Mastercard said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$106.83

2.6 (2.49%)

, FOXA

21st Century Fox

$33.66

0.36 (1.08%)

09:08
12/12/17
12/12
09:08
12/12/17
09:08
Periodicals
Disney, 21st Century Fox deal expected on Thursday, CNBC reports »

Disney (DIS) and 21st…

DIS

Disney

$106.83

2.6 (2.49%)

FOXA

21st Century Fox

$33.66

0.36 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACXM

Acxiom

09:07
12/12/17
12/12
09:07
12/12/17
09:07
Hot Stocks
Acxiom and RedPoint expand partnership »

RedPoint Global announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLNS

Colony NorthStar

$12.21

0.03 (0.25%)

09:07
12/12/17
12/12
09:07
12/12/17
09:07
Hot Stocks
Colony NorthStar to combine retail distribution business with S2K »

Colony NorthStar has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:07
12/12/17
12/12
09:07
12/12/17
09:07
General news
S&P, Dow higher as investors await Fed »

The major averages are…

CAR

Avis Budget

$41.16

0.6 (1.48%)

09:06
12/12/17
12/12
09:06
12/12/17
09:06
Hot Stocks
Avis Budget and Continental team up to enable KaaS technology »

Avis Budget Group and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

INFY

Infosys

$15.86

0.18 (1.15%)

09:06
12/12/17
12/12
09:06
12/12/17
09:06
Hot Stocks
Infosys BPO announces partnership with Tradeshift »

Tradeshift announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$86.55

0.14 (0.16%)

09:05
12/12/17
12/12
09:05
12/12/17
09:05
Recommendations
Darden analyst commentary  »

Darden price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 08

    Jan

MAT

Mattel

$15.37

0.33 (2.19%)

09:05
12/12/17
12/12
09:05
12/12/17
09:05
Technical Analysis
Technical View: Mattel falls, levels to watch »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCHX

Marchex

$3.19

0.01 (0.31%)

09:05
12/12/17
12/12
09:05
12/12/17
09:05
Hot Stocks
Marchex announces special 50c cash dividend for common stock »

Marchex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$123.30

0.49 (0.40%)

09:04
12/12/17
12/12
09:04
12/12/17
09:04
Hot Stocks
Pratt & Whitney signs 12-year EngineWise Fleet Management pact with S7 Airlines »

Pratt & Whitney, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$23.67

0.02 (0.08%)

09:04
12/12/17
12/12
09:04
12/12/17
09:04
Initiation
Invitation Homes initiated  »

Invitation Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KR

Kroger

$26.58

-0.1 (-0.37%)

09:04
12/12/17
12/12
09:04
12/12/17
09:04
Hot Stocks
Kroger teams up with Chase Pay to offer mobile payments »

The Kroger is teaming up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$5.03

0.13 (2.65%)

, GPS

Gap

$33.60

0.11 (0.33%)

09:03
12/12/17
12/12
09:03
12/12/17
09:03
Hot Stocks
Pandora names Aimee Lapic as Chief Marketing Officer, effective December 13 »

Pandora (P) announced…

P

Pandora

$5.03

0.13 (2.65%)

GPS

Gap

$33.60

0.11 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ALLY

Ally Financial

$28.77

0.12 (0.42%)

09:02
12/12/17
12/12
09:02
12/12/17
09:02
Hot Stocks
Ally Financial appoints Jenn LaClair as CFO designate »

Ally Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

ACER

Acer Therapeutics

$14.15

-0.42 (-2.88%)

09:02
12/12/17
12/12
09:02
12/12/17
09:02
Syndicate
Acer Therapeutics 917K share Spot Secondary priced at $12.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ACM

Aecom

$38.51

-0.06 (-0.16%)

09:02
12/12/17
12/12
09:02
12/12/17
09:02
Hot Stocks
Aecom raises five-year adjusted EPS growth forecast to 12%-15% »

AECOM will hold its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

OAS

Oasis Petroleum

09:00
12/12/17
12/12
09:00
12/12/17
09:00
Syndicate
Oasis Petroleum 32M share Spot Secondary priced at $9.55 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

PRSC

Providence Service

$58.26

0.08 (0.14%)

09:00
12/12/17
12/12
09:00
12/12/17
09:00
Syndicate
Providence Service 320K share Block Trade priced at $56.75 »

Jefferies acted as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.